|
TENX Tenax Therapeutics Inc 34956 |
| Income Statement |
|
Net Income
|
2026-03-31
|
$-15,716,000.00 |
| Balance Sheet |
|
Current Assets
|
$123,178,000.00 |
|
Assets
|
$123,178,000.00 |
|
Current Liabilities
|
$8,486,000.00 |
|
Liabilities
|
$8,486,000.00 |
|
Equity
|
$114,692,000.00 |
|
Shares Out
|
24275500.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-9,309,000.00 |
| Market Analysis |
Market Cap
|
$366,560,050.00 |
|
Price
|
$13.40 |
|
BVPS
|
4.72 |
|
PB
|
3.20 |
|
EPS
|
-0.35 |
|
FCF
|
$-9,311,843.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:32 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:29 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view TENX documents filed with the SEC.
TENX Filings
Clear
